Clearance of apoptotic β-cells is reduced in neonatal autoimmune diabetes-prone rats

Cell Death and Differentiation

Volumn 9, Issue 4, 2002, Pages 457-464

  O'Brien, B A ^a   Fieldus, W E ^a   Field, C J ^b   Finegood, D T ^a  

^a SIMON FRASER UNIVERSITY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Apoptosis; Autoimmunity; Clearance; Diabetes

Indexed keywords

ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BIRTH; BREEDING; CELL DEATH; CELL DIVISION; CELL LOSS; CLEARANCE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; HISTOCHEMISTRY; IN VITRO STUDY; INCIDENCE; LYMPHOCYTE COUNT; MATHEMATICAL MODEL; NEWBORN; NICK END LABELING; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; RAT STRAIN; THYMOCYTE;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; DIABETES MELLITUS, TYPE 1; FEMALE; INSULIN; ISLETS OF LANGERHANS; MACROPHAGES; MALE; PHAGOCYTOSIS; RATS; THYMUS GLAND;

ANIMALIA;

EID: 0036316723     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400973     Document Type: Article

References (46)

1. Morphological criteria for identifying apoptosis
2. Morphologic and biochemical hallmarks of apoptosis
3. Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias
4. Apoptosis in the human embryo
5. Apoptosis: Its significance in cancer and cancer therapy
6. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis
7. Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis
8. Thyroid cell apoptosis. A new understanding of thyroid autoimmunity
9. The pancreatic islets in diabetes
10. Type I diabetes mellitus: A chronic autoimmune disease
11. On the pathogenesis of insulin-dependent diabetes mellitus in man: A paradigm in transition
12. Apoptosis is the mode of beta cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse
13. Beta cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model
14. The role of Fas in autoimmune diabetes
15. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis
16. Neonatal β-cell apoptosis: A trigger for autoimmune diabetes?
17. The apoptosis cascade - Morphological and immunohistochemical methods for its visualization
18. Dynamics of β-cell mass in the growing rat pancreas. Estimation with a simple mathematical model
19. Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat
20. Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor
21. Increased and persistent circulating levels of insulin-like growth factor II in neonatal transgenic mice suppresses developmental apoptosis in the pancreatic islets
22. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes
23. Distinct modes of macrophage recognition for apoptotic and necrotic cells are not specified exclusively by phosphatidylserine exposure
24. Induction of antigen presentation by macrophages after phagocytosis of tumour apoptotic cells
25. Cell death: The significance of apoptosis
26. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor
27. Augmented levels of macrophage and Th1 cell-related cytokine mRNA in submandibular glands of MRL/Ipr mice with autoimmune sialoadenitis
28. Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493; a macrophage-deactivating agent
29. Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies
30. Low dose streptozotocin-induced diabetes in mice. Electron microscopy reveals single cell insulitis before diabetes onset
31. Evidence for initial involvement of macrophage in development of insulitis in NOD mice
32. Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets and pre-diabetic BB rats
33. Abnormal TNF-alpha production in diabetes-prone BB rats: Enhanced TNF-alpha expression and defective PGE2 feedback inhibition
34. Cytokines in autoimmune disorders
35. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha
36. TNF-alpha enhances colony-stimulating factor-1-induced macrophage accumulation in autoimmune renal disease
37. Neonatal development of lymphoid organs and specific immune responses in situ in diabetes-prone BB rats
38. Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium
39. Hematopoietic stem cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: Defective regulation of cytokine receptors and protein kinase C
40. Splenic macrophages from the NOD mouse are defective in the ability to present antigen
41. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
42. Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2
43. Macrophages that have ingested apoptotic cells in vitro inhibit pro-inflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE-2 and PAF
44. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
45. Systemic exposure to irradiated apoptotic cells induces autoantibody production
46. Immature dendritic cells phagocytose apoptotic cells via αv β5 and CD36, and cross-present antigens to cytotoxic T lymphocytes